Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,515 | -21,471 | -11,330 | 132,330 | 75,935 |
| Depreciation Amortization | -2,736 | -1,807 | -735 | 815 | 1,274 |
| Accounts receivable | 63,823 | 80,240 | 80,034 | -83,234 | -2,996 |
| Accounts payable and accrued liabilities | 1,556 | 1,001 | 5,975 | -962 | 704 |
| Other Working Capital | 18,168 | 37,356 | 66,143 | -68,532 | 16,219 |
| Other Operating Activity | -51,077 | -68,132 | -81,320 | 97,502 | 10,543 |
| Operating Cash Flow | $-781 | $27,187 | $58,767 | $77,919 | $101,679 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,366 | -3,108 | -2,141 | -3,256 | -2,501 |
| Purchase Of Investment | -334,667 | -293,859 | -203,852 | -223,968 | -194,975 |
| Sale Of Investment | 270,377 | 164,959 | 109,928 | 85,581 | 29,000 |
| Investing Cash Flow | $-67,656 | $-132,008 | $-96,065 | $-141,643 | $-168,476 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 113,441 | 113,427 | 112,856 | 33,645 | 33,185 |
| Financing Cash Flow | $113,441 | $113,427 | $112,856 | $33,645 | $33,185 |
| Beginning Cash Position | 70,395 | 70,395 | 70,395 | 100,474 | 100,474 |
| End Cash Position | 115,399 | 79,001 | 145,953 | 70,395 | 66,862 |
| Net Cash Flow | $45,004 | $8,606 | $75,558 | $-30,079 | $-33,612 |
| Free Cash Flow | |||||
| Operating Cash Flow | -781 | 27,187 | 58,767 | 77,919 | 101,679 |
| Capital Expenditure | -3,366 | -3,108 | -2,141 | -3,256 | -2,501 |
| Free Cash Flow | -4,147 | 24,079 | 56,626 | 74,663 | 99,178 |